These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 2564806

  • 1. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH.
    Cancer Res; 1989 Apr 15; 49(8):2087-90. PubMed ID: 2564806
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 3. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 4. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Oct 15; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 5. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Bodey B, Bodey B, Gröger AM, Luck JV, Siegel SE, Taylor CR, Kaiser HE.
    Anticancer Res; 1997 Oct 15; 17(2B):1319-30. PubMed ID: 9137492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH, Bièche I, Hacène K, Lidereau R.
    Mod Pathol; 1994 Dec 15; 7(9):900-5. PubMed ID: 7892157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
    Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE.
    Cancer Res; 1988 Mar 01; 48(5):1238-43. PubMed ID: 2893663
    [Abstract] [Full Text] [Related]

  • 13. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M, Roagna R, Ponzone R, De Bortoli M, Dati C, Sismondi P.
    Anticancer Res; 1994 Mar 01; 14(3B):1441-50. PubMed ID: 7915096
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
    Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T.
    Cancer Res; 1991 Feb 01; 51(3):1034-8. PubMed ID: 1670998
    [Abstract] [Full Text] [Related]

  • 15. Comparison of EGFR, c-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer.
    Hainsworth PJ, Henderson MA, Stillwell RG, Bennett RC.
    Eur J Surg Oncol; 1991 Feb 01; 17(1):9-15. PubMed ID: 1671658
    [Abstract] [Full Text] [Related]

  • 16. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
    Rhee J, Han SW, Oh DY, Kim JH, Im SA, Han W, Park IA, Noh DY, Bang YJ, Kim TY.
    BMC Cancer; 2008 Oct 23; 8():307. PubMed ID: 18947390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
    Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK, Busch H.
    Cancer Res; 1991 Apr 15; 51(8):1973-8. PubMed ID: 1672621
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.